132 related articles for article (PubMed ID: 18763362)
21. Renin inhibition--benefit beyond hypertension control.
Kher V
J Assoc Physicians India; 2009 Jul; 57():518-20, 525. PubMed ID: 20329413
[TBL] [Abstract][Full Text] [Related]
22. Role of angiotensin receptor blockers in diabetes: implications of recent clinical trials.
McFarlane SI
Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1363-71. PubMed ID: 19900019
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for diabetic nephropathy: a retrospective comparison.
Robles NR; Romero B; Fernandez-Carbonero E; Sánchez-Casado E; Cubero JJ
J Renin Angiotensin Aldosterone Syst; 2009 Dec; 10(4):195-200. PubMed ID: 20026868
[TBL] [Abstract][Full Text] [Related]
24. Renin-angiotensin system blocking drugs.
Robles NR; Cerezo I; Hernandez-Gallego R
J Cardiovasc Pharmacol Ther; 2014 Jan; 19(1):14-33. PubMed ID: 24038019
[TBL] [Abstract][Full Text] [Related]
25. Beyond blood pressure: evidence for cardiovascular, cerebrovascular, and renal protective effects of renin-angiotensin system blockers.
Verdecchia P; Gentile G; Angeli F; Reboldi G
Ther Adv Cardiovasc Dis; 2012 Apr; 6(2):81-91. PubMed ID: 22528743
[TBL] [Abstract][Full Text] [Related]
26. Use of ACE inhibitors or angiotensin receptor blockers and survival in patients on peritoneal dialysis.
Fang W; Oreopoulos DG; Bargman JM
Nephrol Dial Transplant; 2008 Nov; 23(11):3704-10. PubMed ID: 18567695
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of Angiotensin receptor blockers in cardiovascular disease.
Maggioni AP
Cardiovasc Drugs Ther; 2006 Aug; 20(4):295-308. PubMed ID: 16915347
[TBL] [Abstract][Full Text] [Related]
28. Rationale for double renin-angiotensin-aldosterone system blockade.
Unger T; Stoppelhaar M
Am J Cardiol; 2007 Aug; 100(3A):25J-31J. PubMed ID: 17666194
[TBL] [Abstract][Full Text] [Related]
29. Angiotensin receptor blockers: role in hypertension management, cardiovascular risk reduction, and nephropathy.
Basile J; Toth PP
South Med J; 2009 Oct; 102(10 Suppl):S1-S12. PubMed ID: 19834426
[TBL] [Abstract][Full Text] [Related]
30. ARBs and ACEis together in the treatment of hypertension and its complications? current practical recommendations.
Ruilope LM; Segura J
Expert Opin Pharmacother; 2010 Nov; 11(16):2619-23. PubMed ID: 20977398
[TBL] [Abstract][Full Text] [Related]
31. Angiotensin-converting enzyme inhibition and fibrinolytic balance.
Matsumoto T; Horie M
Hypertens Res; 2011 Apr; 34(4):448-9. PubMed ID: 21326308
[No Abstract] [Full Text] [Related]
32. Renin-angiotensin-aldosterone system blockade and renal protection: angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers?
Ruilope LM
Acta Diabetol; 2005 Apr; 42 Suppl 1():S33-41. PubMed ID: 15868118
[TBL] [Abstract][Full Text] [Related]
33. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and the risk of developing rheumatoid arthritis in antihypertensive drug users.
de Jong HJ; Vandebriel RJ; Saldi SR; van Dijk L; van Loveren H; Cohen Tervaert JW; Klungel OH
Pharmacoepidemiol Drug Saf; 2012 Aug; 21(8):835-43. PubMed ID: 22674737
[TBL] [Abstract][Full Text] [Related]
34. Combination ACE inhibitor and angiotensin receptor blocker therapy - future considerations.
Sica DA
J Clin Hypertens (Greenwich); 2007 Jan; 9(1):78-86. PubMed ID: 17215664
[TBL] [Abstract][Full Text] [Related]
35. Antihypertensive drugs and fibrinolytic function.
Fogari R; Zoppi A
Am J Hypertens; 2006 Dec; 19(12):1293-9. PubMed ID: 17161777
[TBL] [Abstract][Full Text] [Related]
36. Effect of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers on the rate of new-onset diabetes mellitus: a review and pooled analysis.
McCall KL; Craddock D; Edwards K
Pharmacotherapy; 2006 Sep; 26(9):1297-306. PubMed ID: 16945052
[TBL] [Abstract][Full Text] [Related]
37. ACE inhibitors or angiotensin II receptor blockers in dialysed patients and erythropoietin resistance.
Saudan P; Halabi G; Perneger T; Wasserfallen JB; Wauters JP; Martin PY;
J Nephrol; 2006; 19(1):91-6. PubMed ID: 16523432
[TBL] [Abstract][Full Text] [Related]
38. Comparative role of angiotensin receptor blockers versus other agents in the management of hypertension, cardiovascular disease and nephropathy.
Tempelhof MW
South Med J; 2009 Dec; 102(12):1201-2. PubMed ID: 20016423
[No Abstract] [Full Text] [Related]
39. Choosing an angiotensin-receptor blocker: blood pressure lowering, cardiovascular protection or both?
Neldam S
Future Cardiol; 2010 Jan; 6(1):129-35. PubMed ID: 20014992
[TBL] [Abstract][Full Text] [Related]
40. Pulse pressure and dual angiotensin blockade.
Safar ME
Am J Hypertens; 2008 Feb; 21(2):133. PubMed ID: 18268484
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
